Disopyramide Phosphate

磷酸丙吡胺

Report date: 2026/03/16 20:01:47
NME

Base Information

Drug NameDisopyramide Phosphate
Drug Alias Name达舒平disopiramidaDisopyramidum磷酸双异丙吡胺吡二丙胺 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsParoxysmal Supraventricular TachycardiaAtrial Premature ComplexesAtrial Fibrillation +[4] 
Global Approved IndicationsParoxysmal Supraventricular TachycardiaAtrial Premature ComplexesAtrial Fibrillation +[4] 
Approved Indications in ChinaArrhythmias, Cardiac
Original Approved Country/TerritoryUnited States
Original Approved Date1977/09/01
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesCheplapharm Arzneimittel GmbhPfizer IncChangzhou Kangpu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsParoxysmal Supraventricular TachycardiaAtrial Premature ComplexesAtrial Fibrillation +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeC01BA03
Related LinksWikipediaDrugBankKEGG